Pradeep Chaluvally-Raghavan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Cancer Stem Cells

Bioinformatics Analysis

Top Venues

NPJ precision oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, Deepak Parashar, Ishaque P Kadamberi, Wei Xiong, Hui Deng, Jasmine George, Sudhir Kumar, Sonam Mittal, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, Deepak Parashar, Ishaque P Kadamberi, Wei Xiong, Hui Deng, Jasmine George, Sudhir Kumar, Sonam Mittal, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, Deepak Parashar, Ishaque P Kadamberi, Wei Xiong, Hui Deng, Jasmine George, Sudhir Kumar, Sonam Mittal, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, Deepak Parashar, Ishaque P Kadamberi, Wei Xiong, Hui Deng, Jasmine George, Sudhir Kumar, Sonam Mittal, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Deepak Parashar, Anjali Geethadevi, Sonam Mittal, Lindsey A McAlarnen, Jasmine George, Ishaque P Kadamberi, Prachi Gupta, Denise S Uyar, Elizabeth E Hopp, Holli Drendel, Erin A Bishop, William H Bradley, Kathleen M Bone, Janet S Rader, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 14 (4) (2022)
Deepak Parashar, Anjali Geethadevi, Sonam Mittal, Lindsey A McAlarnen, Jasmine George, Ishaque P Kadamberi, Prachi Gupta, Denise S Uyar, Elizabeth E Hopp, Holli Drendel, Erin A Bishop, William H Bradley, Kathleen M Bone, Janet S Rader, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14 , 958. Cancers 14 (10) (2022)
Sudhir Kumar, Sonam Mittal, Prachi Gupta, Mona Singh, Pradeep Chaluvally-Raghavan, Sunila Pradeep
Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment. Cancers 14 (21) (2022)
Deepak Parashar, Anjali Geethadevi, Donna McAllister, Johnathan Ebben, Francis C Peterson, Davin R Jensen, Erin Bishop, Sunila Pradeep, Brian F Volkman, Michael B Dwinell, Pradeep Chaluvally-Raghavan, Michael A James
Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance. NPJ precision oncology 5 (1) (2021)
Anjali Geethadevi, Bindu Nair, Deepak Parashar, Zhiqiang Ku, Wei Xiong, Hui Deng, Yongsheng Li, Jasmine George, Donna M McAllister, Yunguang Sun, Ishaque P Kadamberi, Prachi Gupta, Michael B Dwinell, William H Bradley, Janet S Rader, Hallgeir Rui, Robert F Schwabe, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer research 81 (20) (2021)